Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation

被引:30
|
作者
Aguilar, Eduardo [2 ]
Maria Garcia-Diaz, Ana [3 ]
Sanchez Munoz-Torrero, Juan Francisco [4 ]
Ramon Alvarez, Lorenzo [5 ]
Piedecausa, Mar [6 ]
Arnedo, Gemma [7 ]
Monreal, Manuel [1 ]
机构
[1] Hosp Badalona Germans Trias & Pujol, Med Interna Serv, Dept Internal Med, Badalona 08916, Barcelona, Spain
[2] Hosp Alcaniz, Dept Internal Med, Alcaniz, Teruel, Spain
[3] ABS Gaudi, Primary Healthcare, Barcelona, Spain
[4] Hosp San Pedro de Alcantara, Dept Internal Med, Caceres, Spain
[5] Hosp Terrassa, Dept Vasc Surg, Barcelona, Spain
[6] Hosp Gen Univ Elche, Dept Internal Med, Alicante, Spain
[7] Hosp Badalona Germans Trias & Pujol, Dept Vasc Surg, Badalona 08916, Barcelona, Spain
关键词
Atrial fibrillation; Ayocardial infarction; Atroke; Bleeding; Antiplatelets; Anticoagulants; ANTITHROMBOTIC THERAPY; MYOCARDIAL-INFARCTION; EUROPEAN-SOCIETY; PREVENT STROKE; TASK-FORCE; RISK; ASPIRIN; CLOPIDOGREL; MANAGEMENT; WARFARIN;
D O I
10.1016/j.thromres.2012.05.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The influence of atrial fibrillation (AF) on outcome in patients with symptomatic atherosclerotic disease has not been thoroughly studied. Methods: FRENA is an ongoing registry of stable outpatients with coronary (CAD), cerebrovascular (CVD), or peripheral (PAD) artery disease. With the aim to guide therapy, we assessed the incidence of subsequent myocardial infarction (MI), ischemic stroke or major bleeding in patients with AF, according to initial presentation. Results: As of June 2011, 3848 patients were recruited: 1436 had CAD, 1104 CVD, and 1308 had PAD. Of these, 470 (12%) had AF: 151 patients with CAD, 157 with CVD, and 162 with PAD. Over a mean follow-up of 16 +/- 13 months, 19 patients with AF developed acute MI, 22 ischemic stroke and 7 bled. Among AF patients with CAD, the incidence of subsequent MI (5.00 events per 100 patient-years; 95% CI: 2.54-8.91) was non-significantly higher than that of stroke (1.48; 95% CI: 0.38-4.04) or major bleeding (1.47; 95% CI: 0.37-4.01). Among those with CVD, the incidence of stroke (5.61; 95% CI: 2.95-9.75) exceeded that of MI (no events) or major bleeding (0.51; 95% CI: 1.24-6.36). Among those with PAD, the incidence of MI (4.41; 95% CI: 2.15-8.10) and stroke (3.93; 95% CI: 1.82-7.46) were similar. Conclusions: CAD patients with AF are at a higher risk of subsequent MI than of stroke. Among those with CVD, the risk of stroke far exceeds that of MI. Those with PAD have a high and similar risk for both events. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:390 / 395
页数:6
相关论文
共 50 条
  • [41] Clinical characteristics and one year outcomes in Chinese atrial fibrillation patients with stable coronary artery disease: a population-based study
    Bai, Ying
    Zhu, Jun
    Yang, Yan-Min
    Liang, Yan
    Tan, Hui-Qiong
    Wang, Juan
    Huang, Bi
    Zhang, Han
    Shao, Xing-Hui
    JOURNAL OF GERIATRIC CARDIOLOGY, 2016, 13 (08) : 665 - 671
  • [42] Antithrombotic Regimens in Patients With Atrial Fibrillation and Coronary Disease Optimizing Efficacy and Safety
    Markowitz, Steven M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (11) : 990 - 991
  • [43] Anemia and Outcome in Outpatients With Peripheral Artery Disease
    Perez, Paulina
    Esteban, Carlos
    Jimenez Caballero, Pedro Enrique
    Sanchez Munoz-Torrero, Juan Francisco
    Pascual Soria, Maria Teresa
    Aguilar, Eduardo
    Alvarez Rodriguez, Lorenzo Ramon
    Carles Sahuquillo, Joan
    Garcia Diaz, Ana Maria
    Monreal, Manuel
    ANGIOLOGY, 2016, 67 (05) : 484 - 489
  • [44] Coronary artery, cerebrovascular and peripheral vascular disease
    Pedagogos, Eugenie
    NEPHROLOGY, 2010, 15 : S19 - S23
  • [45] Antithrombotic Therapy for Atrial Fibrillation and Coronary Artery Disease in Patients With Prior Atherothrombotic Disease: A Post Hoc Analysis of the AFIRE Trial
    Matsuzawa, Yasushi
    Kimura, Kazuo
    Yasuda, Satoshi
    Kaikita, Koichi
    Akao, Masaharu
    Ako, Junya
    Matoba, Tetsuya
    Nakamura, Masato
    Miyauchi, Katsumi
    Hagiwara, Nobuhisa
    Hirayama, Atsushi
    Matsui, Kunihiko
    Ogawa, Hisao
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (21):
  • [46] Atrial fibrillation and coronary artery disease: which antithrombotic treatment strategy?
    Lamberts, Morten
    Dewilde, Willem
    Hansen, Morten Lock
    CURRENT OPINION IN CARDIOLOGY, 2014, 29 (06) : 595 - 600
  • [47] Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients
    Hess, Connie N.
    Broderick, Samuel
    Piccini, Jonathan P.
    Alexander, Karen P.
    Newby, L. Kristin
    Shaw, Linda K.
    Mahaffey, Kenneth W.
    Alexander, John H.
    Peterson, Eric D.
    Granger, Christopher B.
    Lopes, Renato D.
    AMERICAN HEART JOURNAL, 2012, 164 (04) : 607 - 615
  • [48] Radiofrequency catheter ablation prior to percutaneous coronary intervention in patients with atrial fibrillation coexisting with stable coronary artery disease: a single-center pilot study
    Kawada, Satoshi
    Watanabe, Atsuyuki
    Morimoto, Yoshimasa
    Nakagawa, Koji
    Nishii, Nobuhiro
    Nakamura, Kazufumi
    Morita, Hiroshi
    Ito, Hiroshi
    HEART AND VESSELS, 2019, 34 (04) : 632 - 640
  • [49] Efficacy and safety of oral anticoagulants in elderly patients with stable coronary artery disease and atrial fibrillation
    Zhang, Xu
    Wu, Yangxun
    Lv, Chao
    Zhang, Shizhao
    Liu, Haiping
    Wang, Yuyan
    Zou, Yuting
    Qin, Liu'an
    Zhang, Junmeng
    Yin, Tong
    THROMBOSIS JOURNAL, 2022, 20 (01)
  • [50] β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease
    Bangalore, Sripal
    Steg, Ph Gabriel
    Deedwania, Prakash
    Crowley, Kevin
    Eagle, Kim A.
    Goto, Shinya
    Ohman, E. Magnus
    Cannon, Christopher P.
    Smith, Sidney C., Jr.
    Zeymer, Uwe
    Hoffman, Elaine B.
    Messerli, Franz H.
    Bhatt, Deepak L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (13): : 1340 - 1349